115 related articles for article (PubMed ID: 24357809)
1. In systemic sclerosis patients, bosentan is safe and effective for digital ulcer prevention and it seems to attenuate the development of pulmonary arterial hypertension.
Romaniello A; Viola G; Salsano F; Rosato E
Rheumatology (Oxford); 2014 Mar; 53(3):570-1. PubMed ID: 24357809
[No Abstract] [Full Text] [Related]
2. New hope for systemic sclerosis patients with digital ulcers.
Varga J
Curr Rheumatol Rep; 2005 Apr; 7(2):127-8. PubMed ID: 15760591
[No Abstract] [Full Text] [Related]
3. Successful treatment of systemic sclerosis digital ulcers and pulmonary arterial hypertension with endothelin receptor antagonist bosentan.
Humbert M; Cabane J
Rheumatology (Oxford); 2003 Jan; 42(1):191-3. PubMed ID: 12509640
[No Abstract] [Full Text] [Related]
4. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.
Korn JH; Mayes M; Matucci Cerinic M; Rainisio M; Pope J; Hachulla E; Rich E; Carpentier P; Molitor J; Seibold JR; Hsu V; Guillevin L; Chatterjee S; Peter HH; Coppock J; Herrick A; Merkel PA; Simms R; Denton CP; Furst D; Nguyen N; Gaitonde M; Black C
Arthritis Rheum; 2004 Dec; 50(12):3985-93. PubMed ID: 15593188
[TBL] [Abstract][Full Text] [Related]
5. Bosentan: a review of its use in the management of digital ulcers associated with systemic sclerosis.
Dhillon S
Drugs; 2009 Oct; 69(14):2005-24. PubMed ID: 19747014
[TBL] [Abstract][Full Text] [Related]
6. Liver impairment after concomitant administration of bosentan and clarithromycin in systemic sclerosis.
Caramaschi P; Mahamid H; Bambara LM; Biasi D
Joint Bone Spine; 2010 Jan; 77(1):81-2. PubMed ID: 20022782
[No Abstract] [Full Text] [Related]
7. Bosentan for digital ulcers in patients with systemic sclerosis: a prospective 3-year followup study.
Tsifetaki N; Botzoris V; Alamanos Y; Argyriou E; Zioga A; Drosos AA
J Rheumatol; 2009 Jul; 36(7):1550-2. PubMed ID: 19567637
[No Abstract] [Full Text] [Related]
8. Bosentan for digital ulcers prevention does not worsen cardiopulmonary exercise test parameters in SSc patients with interstitial lung disease.
Romaniello A; Gigante A; Di Paolo M; Tallerini G; Barbano B; Amoroso D; Palange P; Rosato E
Int J Cardiol; 2016 Nov; 223():113-115. PubMed ID: 27537734
[No Abstract] [Full Text] [Related]
9. A higher degree of criticism about the effectiveness of bosentan for digital ulcers in scleroderma patients, as for interstitial disease, is also necessary: comment on the article by Seibold et al.
Bredemeier M
Arthritis Rheum; 2010 Oct; 62(10):3128-9; author reply 3129-30. PubMed ID: 20597113
[No Abstract] [Full Text] [Related]
10. Bosentan as a rescue therapy in scleroderma refractory digital ulcers.
Chamaillard M; Heliot-Hosten I; Constans J; Taïeb A
Arch Dermatol; 2007 Jan; 143(1):125-6. PubMed ID: 17224564
[No Abstract] [Full Text] [Related]
11. Connective tissue diseases: Treatment of digital ulcers in systemic sclerosis.
Lambova S; Müller-Ladner U
Nat Rev Rheumatol; 2011 Jan; 7(1):5-6. PubMed ID: 21119606
[No Abstract] [Full Text] [Related]
12. Bosentan improves skin perfusion of hands in patients with systemic sclerosis with pulmonary arterial hypertension.
Rosato E; Molinaro I; Borghese F; Rossi C; Pisarri S; Salsano F
J Rheumatol; 2010 Dec; 37(12):2531-9. PubMed ID: 20810512
[TBL] [Abstract][Full Text] [Related]
13. Bosentan for the treatment of systemic sclerosis-associated pulmonary arterial hypertension, pulmonary fibrosis and digital ulcers.
Jain M; Varga J
Expert Opin Pharmacother; 2006 Aug; 7(11):1487-501. PubMed ID: 16859432
[TBL] [Abstract][Full Text] [Related]
14. Bosentan in clinical practice for treating digital and other ischemic ulcers in Spanish patients with systemic sclerosis: IBER-DU cohort study.
Roman Ivorra JA; Simeon CP; Alegre Sancho JJ; Egurbide MV; Castillo MJ; Lloria X; Fonollosa V
J Rheumatol; 2011 Aug; 38(8):1631-5. PubMed ID: 21632679
[TBL] [Abstract][Full Text] [Related]
15. Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension.
Mathai SC; Girgis RE; Fisher MR; Champion HC; Housten-Harris T; Zaiman A; Hassoun PM
Eur Respir J; 2007 Mar; 29(3):469-75. PubMed ID: 17079256
[TBL] [Abstract][Full Text] [Related]
16. Resolution of severe digital ulceration during a course of Bosentan therapy.
Snyder MJ; Jacobs MR; Grau RG; Wilkes DS; Knox KS
Ann Intern Med; 2005 May; 142(9):802-3. PubMed ID: 15867420
[No Abstract] [Full Text] [Related]
17. Successful treatment of systemic sclerosis-related digital ulcers and sarcoidosis with endothelin receptor antagonist (bosentan) therapy.
Tillon J; Hervé F; Chevallier D; Muir JF; Levesque H; Marie I
Br J Dermatol; 2006 May; 154(5):1000-2. PubMed ID: 16634913
[No Abstract] [Full Text] [Related]
18. A possible contribution of elevated serum clusterin levels to the inhibition of digital ulcers and pulmonary arterial hypertension in systemic sclerosis.
Yanaba K; Asano Y; Tada Y; Sugaya M; Kadono T; Sato S
Arch Dermatol Res; 2012 Aug; 304(6):459-63. PubMed ID: 22350181
[TBL] [Abstract][Full Text] [Related]
19. [Bosentan for treatment of active digital ulcers in patients with systemic sclerosis].
Launay D; Diot E; Pasquier E; Mouthon L; Boullanger N; Fain O; Jego P; Carpentier P; Hatron PY; Hachulla E
Presse Med; 2006 Apr; 35(4 Pt 1):587-92. PubMed ID: 16614599
[TBL] [Abstract][Full Text] [Related]
20. Endothelin receptor antagonist bosentan improves the dermal sclerosis in a patient with systemic sclerosis.
Nishibu A; Sakai E; Oyama N; Yamamoto T
Australas J Dermatol; 2012 May; 53(2):e32-3. PubMed ID: 22571581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
